Rallybio Corp (RLYB)
1.77
-0.09
(-4.84%)
USD |
NASDAQ |
May 17, 16:00
1.77
0.00 (0.00%)
After-Hours: 20:00
Rallybio Total Liabilities (Quarterly): 10.20M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.20M |
| December 31, 2023 | 9.436M |
| September 30, 2023 | 9.613M |
| June 30, 2023 | 8.319M |
| March 31, 2023 | 7.121M |
| December 31, 2022 | 11.12M |
| September 30, 2022 | 11.72M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.756M |
| March 31, 2022 | 6.317M |
| December 31, 2021 | 6.583M |
| September 30, 2021 | 7.379M |
| June 30, 2021 | 189.46M |
| March 31, 2021 | 188.13M |
| December 31, 2020 | 5.855M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.855M
Minimum
Dec 2020
189.46M
Maximum
Jun 2021
34.22M
Average
8.878M
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 101.95B |
| Adial Pharmaceuticals Inc | 0.6531M |
| Eliem Therapeutics Inc | 2.95M |
| Alpine Immune Sciences Inc | 40.94M |
| Monogram Orthopaedics Inc | 2.314M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.36M |
| Shareholders Equity (Quarterly) | 89.16M |